DMAC - Diamedica Therapeutics Inc. - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Pharmaceutical Preparations - DMAC (1401040)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
 P - Purchase
 S - Sale
 A - Grant
 D - Sale to Iss
 G - Gift
 F - Tax
 M - Option Ex
 X - Option Ex
 C - Cnv Deriv
 W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title     Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10%own
  Other
Group by
Sort by
Max Results
Page
   clear
6 results. Finviz - SEC - Yahoo - Stockcharts - Tradingview
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Insider Name

Title

Trade Type  

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

2025-07-23
DMACStahlberg Jan10%P - Purchase$3.50+1,542,8576,764,465+30%+$5,400,000
2025-07-23
DMACVon Koch Thomas10%P - Purchase$3.50+2,857,1428,383,577+52%+$9,999,997
2025-07-23
DMACJacinto Richard II10%P - Purchase$3.50+400,0004,958,823+9%+$1,400,000
2024-06-28
DMACVon Koch Thomas10%P - Purchase$2.50+1,200,0005,526,435+28%+$3,000,000
2024-06-28
DMACStahlberg Jan10%P - Purchase$2.50+1,200,0005,221,608+30%+$3,000,000
2023-11-16
DMACWambeke David J.Chief Business OfficerP - Purchase$2.46+20,000527,114+4%+$49,200

AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top